Therapeutic strategies for acute intermittent porphyria

Acute intermittent porphyria (AIP) is an autosomal dominant disease caused by mutations in porphobilinogen deaminase (PBGD), the third enzyme of the heme synthesis pathway. Symptoms of AIP usually manifest as intermittent acute attacks with occasional neuropsychiatric crises. The management of AIP i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Intractable Rare Dis Res
Autors principals: Zhao, Lanlan, Wang, Xinyang, Zhang, Xiaoning, Liu, Xiantao, Ma, Ningzhen, Zhang, Yiran, Zhang, Songyun
Format: Artigo
Idioma:Inglês
Publicat: International Research and Cooperation Association for Bio & Socio-Sciences Advancement 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7586882/
https://ncbi.nlm.nih.gov/pubmed/33139979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5582/irdr.2020.03089
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars